Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
about
Progress and problems with the use of suicide genes for targeted cancer therapySafety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines.A phase I clinical trial of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in patients with recurrent gynecologic cancerOncolytic viruses: From bench to bedside with a focus on safety.Improving the safety of cell therapy products by suicide gene transferImproving the safety of cell therapy with the TK-suicide geneNew Variants of Tomato Thymidine Kinase 1 Selected for Increased Sensitivity of E. coli KY895 towards AzidothymidineAdenovirus-mediated delivery of herpes simplex virus thymidine kinase administration improves outcome of recurrent high-grade glioma.Bortezomib sensitizes non-small cell lung cancer to mesenchymal stromal cell-delivered inducible caspase-9-mediated cytotoxicity.Gene therapy for ocular diseasesRepublished review: Gene therapy for ocular diseases.A double suicide gene system driven by vascular endothelial growth factor promoter selectively kills human hepatocellular carcinoma cells.Suicide Gene Therapy for Cancer - Current Strategies.Hypoxia/hepatoma dual specific suicide gene expression plasmid delivery using bio-reducible polymer for hepatocellular carcinoma therapy.GUCY2C-targeted cancer immunotherapy: past, present and future.Gene-directed enzyme prodrug therapy.Gene therapy research in Asia.Recent updates in utilizing prodrugs in drug delivery (2013-2015).Drug discovery in advanced prostate cancer: translating biology into therapy.Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.The design and optimization of RNA trans-splicing molecules for skin cancer therapy.Absence of systemic immune response to adenovectors after intraocular administration to children with retinoblastoma
P2860
Q28262370-648D77AB-002B-4018-9751-7CC683A299E8Q33556564-98CD7B29-E247-4F72-A77D-375793460A48Q33786353-1465D3C2-E6D9-4232-88D7-1CD706EE84FCQ34044071-B0B131EF-C4F3-458F-B0B0-9A9DA96A450DQ34453846-10EC5362-DDD4-4422-A9F2-BD8AC955F53FQ34477411-FC7D8E67-215E-4BBE-AF6E-F569C195D2C6Q34480167-293575E8-B022-41A0-BD75-12F95AECF77CQ34506962-985405E7-D429-4136-A732-85046B7B6668Q34576976-1007AE6E-E2C7-43B7-97AB-FA573645BE96Q35160142-187FEBA7-1C0D-4B86-BD76-7855D54EEBDEQ35210756-F6827EB8-4A06-4376-9959-9CAF5F32CDDAQ36825943-8020406F-BA05-4105-98E2-C669CDB48A4AQ37347017-97D1CAB6-1CA0-475A-8F8C-908FB614839EQ37489674-962AF8D0-269E-48EA-B100-EB4BA7AB0D34Q37950928-D749A183-88F8-4315-A4E9-8FE26CFA1F6FQ38262019-68D5955C-D26B-46C2-9B33-3800A6789641Q38654544-CAEBC9AF-E668-4DC7-BD47-5E841809181FQ38702949-9E86BFB5-EDF5-43B0-9850-3B225AEA79D7Q38839110-16AFFCEE-2016-4369-AA94-DE95F066070FQ39444656-9B092B5B-7FB5-43D0-8EC1-6BAF50C60BFEQ41134396-88B150C9-34D9-455D-A7BA-EC9AAF547C92Q42412771-8A684F96-92C0-450D-B9BF-424D1CC67017
P2860
Phase I and biodistribution study of recombinant adenovirus vector-mediated herpes simplex virus thymidine kinase gene and ganciclovir administration in patients with head and neck cancer and other malignant tumors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Phase I and biodistribution st ...... er and other malignant tumors.
@en
type
label
Phase I and biodistribution st ...... er and other malignant tumors.
@en
prefLabel
Phase I and biodistribution st ...... er and other malignant tumors.
@en
P2093
P2860
P356
P1433
P1476
Phase I and biodistribution st ...... er and other malignant tumors.
@en
P2093
P2860
P2888
P304
P356
10.1038/CGT.2009.19
P50
P577
2009-04-10T00:00:00Z
P5875
P6179
1042092665